(Q40975444)

English

Inhibition of human smooth muscle cell proliferation in culture by farnesyl pyrophosphate analogues, inhibitors of in vitro protein: farnesyl transferase

scientific article published on February 1999

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Inhibition of human smooth muscle cell proliferation in culture by farnesyl pyrophosphate analogues, inhibitors of in vitro protein: farnesyl transferase (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

author name string

Cohen LH

1

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Pieterman E

2

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

van Leeuwen RE

3

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Du J

4

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Negre-Aminou P

5

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Valentijn AR

6

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Overhand M

7

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

van der Marel GA

8

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

van Boom JH

9

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

language of work or name

0 references

publication date

1 February 1999

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Biochemical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

57

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

365-373

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

The pathogenesis of atherosclerosis: a perspective for the 1990s

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00322-0

7 January 2021

The intima. Soil for atherosclerosis and restenosis.

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00322-0

7 January 2021

Human arterial smooth muscle cell proliferation in diabetes

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00322-0

7 January 2021

Homocysteine and vascular disease

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00322-0

7 January 2021

Current concepts in restenosis following balloon angioplasty

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00322-0

7 January 2021

Pharmacology of smooth muscle cell replication

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00322-0

7 January 2021

Inhibition of proliferation of human smooth muscle cells by various HMG-CoA reductase inhibitors; comparison with other human cell types

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00322-0

7 January 2021

Requirement for ras proto-oncogene function during serum-stimulated growth of NIH 3T3 cells

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00322-0

7 January 2021

An Essential Role for Rho, Rac, and Cdc42 GTPases in Cell Cycle Progression Through G 1

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00322-0

7 January 2021

Inhibition of purified p21ras farnesyl:protein transferase by Cys-AAX tetrapeptides

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00322-0

7 January 2021

A protein geranylgeranyltransferase from bovine brain: implications for protein prenylation specificity

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00322-0

7 January 2021

Benzodiazepine peptidomimetics: potent inhibitors of Ras farnesylation in animal cells

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00322-0

7 January 2021

Farnesyltransferase inhibitors: Ras research yields a potential cancer therapeutic

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00322-0

7 January 2021

Polylysine and CVIM sequences of K-RasB dictate specificity of prenylation and confer resistance to benzodiazepine peptidomimetic in vitro.

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00322-0

7 January 2021

Different analogues of farnesyl pyrophosphate inhibit squalene synthase and protein:farnesyltransferase to different extents

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00322-0

7 January 2021

p21ras-induced responsiveness of phosphatidylinositol turnover to bradykinin is a receptor number effect

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00322-0

7 January 2021

Posttranslational modification of Ha-ras p21 by farnesyl versus geranylgeranyl isoprenoids is determined by the COOH-terminal amino acid

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00322-0

7 January 2021

Orally active squalene synthase inhibitors: bis((acyloxy)alkyl) prodrugs of the alpha-phosphonosulfonic acid moiety

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00322-0

7 January 2021

Identifiers

10.1016/S0006-2952(98)00322-0

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40975444&oldid=2092781219"